Technical Analysis for SCPH - scPharmaceuticals Inc.
|Grade||Last Price||% Change||Price Change|
SCPH closed down 4.17 percent on Friday, March 23, 2018, on 3.03 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical SCPH trend table...|
|Date||Alert Name||Type||% Chg|
|Mar 23||180 Bearish Setup||Bearish Swing Setup||0.00%|
|Mar 23||Volume Surge||Other||0.00%|
|Mar 23||Lower Bollinger Band Walk||Weakness||0.00%|
|Mar 23||Inside Day||Range Contraction||0.00%|
|Mar 23||Wide Bands||Range Expansion||0.00%|
|Mar 23||Oversold Stochastic||Weakness||0.00%|
|Mar 22||Lower Bollinger Band Walk||Weakness||-4.17%|
|Mar 22||Wide Bands||Range Expansion||-4.17%|
|Mar 22||Lower Bollinger Band Touch||Weakness||-4.17%|
|Mar 22||Oversold Stochastic||Weakness||-4.17%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SCPH news...
|52 Week High||18.17|
|52 Week Low||11.5|
|200-Day Moving Average||0.0|
|50-Day Moving Average||13.7517|
|20-Day Moving Average||15.0473|
|10-Day Moving Average||14.319|
|Average True Range||0.9819|
|Chandelier Exit (Long, 3 ATRs )||15.0093|
|Chandelier Exit (Short, 3 ATRs )||15.2957|
|Upper Bollinger Band||17.8403|
|Lower Bollinger Band||12.2543|
|Percent B (%b)||0.03|
|MACD Signal Line||0.1678|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||13.17|
|Resistance 3 (R3)||13.24||13.06||13.05|
|Resistance 2 (R2)||13.06||12.87||13.03||13.00|
|Resistance 1 (R1)||12.74||12.75||12.65||12.67||12.96|
|Support 1 (S1)||12.24||12.37||12.15||12.17||11.88|
|Support 2 (S2)||12.06||12.25||12.03||11.84|
|Support 3 (S3)||11.74||12.06||11.80|
|Support 4 (S4)||11.67|